These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure. O'Neill JO; Bott-Silverman CE; McRae AT; Troughton RW; Ng K; Starling RC; Young JB Am Heart J; 2005 Feb; 149(2):363-9. PubMed ID: 15846278 [TBL] [Abstract][Full Text] [Related]
25. [Prognostic value of point of care B-type natriuretic peptide testing and GRACE score in patients with acute coronary syndrome]. Sun YH; Wang GL; Fu YY; Xue C; Hu DY Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Aug; 37(8):716-20. PubMed ID: 20021924 [TBL] [Abstract][Full Text] [Related]
26. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis. Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253 [TBL] [Abstract][Full Text] [Related]
27. The clinical value of rapid assay for plasma B-type natriuretic peptide in differentiating congestive heart failure from pulmonary causes of dyspnoea. Zhao SQ; Hu YM; Li Q; Liu XR; Wang M; Zhang WY; Wu T; Nie XL; Zhao N; Wang LR Int J Clin Pract; 2008 Feb; 62(2):214-20. PubMed ID: 18081799 [TBL] [Abstract][Full Text] [Related]
28. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710 [TBL] [Abstract][Full Text] [Related]
29. [Relationship between plasma brain natriuretic peptide concentration and clinical prognosis in patients of acute myocardial infarction]. Wang LF; Wu S; Guan XR; Zhang L; Shen JX; Xue FH Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Mar; 33(3):234-7. PubMed ID: 15929819 [TBL] [Abstract][Full Text] [Related]
30. [The diagnostic application of bedside measurement of plasma brain natriuretic in patients with heart failure]. Shao LW; Han Y; Wang ZK; Sun J Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):99-101. PubMed ID: 15840219 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Ryding AD; Kumar S; Worthington AM; Burgess D Anesthesiology; 2009 Aug; 111(2):311-9. PubMed ID: 19602961 [TBL] [Abstract][Full Text] [Related]
32. Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels. Chin KM; Channick RN; Kim NH; Rubin LJ Chest; 2007 Sep; 132(3):786-92. PubMed ID: 17646224 [TBL] [Abstract][Full Text] [Related]
33. Blood volume and brain natriuretic peptide in congestive heart failure: a pilot study. James KB; Troughton RW; Feldschuh J; Soltis D; Thomas D; Fouad-Tarazi F Am Heart J; 2005 Nov; 150(5):984. PubMed ID: 16290978 [TBL] [Abstract][Full Text] [Related]
34. High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock. Vergès B; Zeller M; Desgrès J; Dentan G; Laurent Y; Janin-Manificat L; L'Huillier I; Rioufol G; Beer JC; Makki H; Rochette L; Gambert P; Cottin Y Eur Heart J; 2005 Sep; 26(17):1734-41. PubMed ID: 15831555 [TBL] [Abstract][Full Text] [Related]
35. B-type natriuretic peptide as a marker for sepsis-induced myocardial depression in intensive care patients. Post F; Weilemann LS; Messow CM; Sinning C; Münzel T Crit Care Med; 2008 Nov; 36(11):3030-7. PubMed ID: 18824903 [TBL] [Abstract][Full Text] [Related]
36. Brain natriuretic peptide as noninvasive marker of the severity of right ventricular dysfunction in chronic thromboembolic pulmonary hypertension. Reesink HJ; Tulevski II; Marcus JT; Boomsma F; Kloek JJ; Vonk Noordegraaf A; Bresser P Ann Thorac Surg; 2007 Aug; 84(2):537-43. PubMed ID: 17643631 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease. Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960 [TBL] [Abstract][Full Text] [Related]
38. Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection. Arnau-Vives MA; Almenar L; Hervas I; Osa A; Martinez-Dolz L; Rueda J; Zorio E; Martinez-Ortiz De Urbina L; Perez JL; Mateo A; Palencia M J Heart Lung Transplant; 2004 Jul; 23(7):850-6. PubMed ID: 15261180 [TBL] [Abstract][Full Text] [Related]
39. Brain natriuretic peptide is a good predictor for outcome in cardiac surgery. Elíasdóttir SB; Klemenzson G; Torfason B; Valsson F Acta Anaesthesiol Scand; 2008 Feb; 52(2):182-7. PubMed ID: 17949462 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of intraoperative brain natriuretic peptide as a predictor of 1-year mortality after liver transplantation. Kim YK; Shin WJ; Song JG; Kim Y; Kim WJ; Kim SH; Hwang GS Transplant Proc; 2011 Jun; 43(5):1684-90. PubMed ID: 21693258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]